Skip to main content
HR 2870 117th Congress House Health Business records Congressional oversight Emergency medical services and trauma care Government information and archives Government studies and investigations Health care coverage and access Health programs administration and funding Health technology, devices, supplies Prescription drugs Public contracts and procurement Public-private cooperation Strategic materials and reserves

Essential Medicines Strategic Stockpile Act of 2021

Introduced: April 28, 2021 Introduced by: Carter, Earl L. "Buddy" Republican · Georgia See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 29, 2021
Referred to the Subcommittee on Health.
Apr 28, 2021
Referred to the House Committee on Energy and Commerce.
Apr 28, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Essential Medicines Strategic Stockpile Act of 2021

This bill requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage.

Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs.

The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.

What's happening now April 29, 2021

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 3

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • BALLARD SPAHR LLP
    for CENCORA, INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Pennsylvania · 3rd Quarter (July 1 - Sep 30) 2025
  • BALLARD SPAHR LLP
    for CENCORA, INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Pennsylvania · 2nd Quarter (Apr 1 - June 30) 2025
  • BALLARD SPAHR LLP
    for CENCORA, INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Pennsylvania · 1st Quarter (Jan 1 - Mar 31) 2025
 Cosponsors 1
All 1 Democratic 1
D
Blunt Rochester, Lisa
Delaware · Apr 28, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2870: Essential Medicines Strategic Stockpile Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-2870/
MLA
"H.R. 2870: Essential Medicines Strategic Stockpile Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-2870/.
Bluebook (legal)
H.R. 2870, 117th Cong. (2026), https://openamerica.io/bill/117-HR-2870/.
Markdown link
[H.R. 2870: Essential Medicines Strategic Stockpile Act of 2021](https://openamerica.io/bill/117-HR-2870/)
Report a problem